Telomerase activity and expression of its RNA component in cervical lesions

Cancer

Volumn 82, Issue 7, 1998, Pages 1319-1327

  Yashima, Kazuo ^a   Ashfaq, Raheela ^b   Nowak, Jan ^c   Von Gruenigen, Vivian ^b   Milchgrub, Sara ^b   Rathi, Asha ^a   Albores Saavedra, Jorge ^b   Shay, Jerry W ^b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

Author keywords

Cervical carcinoma; Human papillomavirus; In situ hybridization; Preneoplasia; Telomerase

Indexed keywords

RNA; TELOMERASE;

ARTICLE; CANCER STAGING; ENZYME ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM; STEM CELL; UTERINE CERVIX CANCER; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IN SITU HYBRIDIZATION; LYMPHOCYTE COUNT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA; TELOMERASE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0032055145     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1319::AID-CNCR15>3.0.CO;2-9     Document Type: Article

References (26)

1. Kurman RJ. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994.
2. zur Hausen H, de Villiers EM. Human papillomaviruses. Annu Rev Microbiol 1994;48:427-47.
3. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-43.
4. Braly P. Preventing cervical cancer. Nat Med 1996;2:749-51.
5. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
6. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-9.
7. Blackburn EH. Structure and function of telomeres. Nature 1991;350(6319):569-73.
8. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science 1995;269:1236-41.
9. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M. Telomerase activity in gynecological tumors. Clin Cancer Res 1996;2: 2023-8.
10. Zheng PS, Iwasaka T, Yamasaki F, Ouchida M, Yokoyama M, Nakao Y, et al. Telomerase activity in gynecologic tumors. Gynecol Oncol 1997;64:171-5.
11. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996;56:645-50.
12. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-7.
13. Tsao J-L, Zhao Y, Lukas J, Yang X, Shah A, Press M, et al. Telomerase activity in normal and neoplastic breast. Clin Cancer Res 1997;3:627-31.
14. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohii H, Yamamoto H, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996;13:433-9.
15. Pao CC, Tseng CJ, Lin CY, Yang FP, Hor JJ, Yao DS, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997;15:1932-7.
16. Workshop NCI. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1991;262:931-4.
17. Piatyszek MA, Kim NW, Weinrich SL, Hiayama K, Hiyama E, Wright WE, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Science 1995;17:1-15.
18. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-5.
19. Yashima K, Piatyrzek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-7.
20. de Roda Husman AM, Snijders PI, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995;7:412-7.
21. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230(4732):1350-4.
22. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
23. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996;34:745-7.
24. Kyo S, Takakura M, Ishikawa H, Sasagawa T, Satake S, Tateno M, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res 1997;57:1863-7.
25. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996;380:79-82.
26. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995;86:899-904.